PTC Therapeutics, Inc. discovers and develops small molecule drugs by applying its integrated RNA biology and chemistry platforms. PTC's compounds modulate gene expression by selectively binding to either RNA targets or proteins that interact with RNA. This approach has progressed the Company's drug discovery programs rapidly from targets to lead optimization. PTC's pipeline includes programs in infectious diseases, oncology, inflammation, and genetic disorders.
PTC Therapeutics Address
100 Corporate Court South Plainfield, NJ United States